根据处罚决定，ST人福被给予警告并罚款850万元，当代集团合计罚款900万元；艾路明因组织领导相 关违法行为，被罚款390万元且7年不得从事证券相关业务；时任ST人福董事长李杰、财务总监吴亚君 分别被罚390万元、340万元，另有8名时任董监高分别被处以50万至250万元不等罚款。 经监管查明，2020年至2022年期间，ST人福（600079）及当代集团存在多项违法事实：一是非经营性 资金占用累计127.85亿元未及时披露，且2020年年度报告遗漏该信息；二是2022年3月下属子公司与关 联方16.45亿元物业资产交易未及时披露，且未载入当年年报；三是2020年至2022年半年度多份财报存 在虚假记载，累计虚增归母净利润超3亿元；四是当代集团隐瞒关联关系，导致公司1亿元股权收购交易 未按规定披露关联信息。 近日，人福医药发布公告称，公司及原控股股东武汉当代科技产业集团股份有限公司（下称"当代集 团"）等12名相关责任人，因信息披露违法违规收到湖北证监局《行政处罚决定书》，合计罚款超2900 万元，时任当代集团实际负责人艾路明被采取7年市场禁入措施。 公告显示，ST人福目前已触及其他风险警示，但未触及重大违法 ...

南财智讯12月29日电，ST人福公告，人福医药集团股份公司、武汉当代科技产业集团股份有限公司、 艾路明（时任当代集团董事）、李杰（时任人福医药董事长）、王学海（时任人福医药董事）、邓霞飞 （时任人福医药董事、总裁）、郑承刚（时任人福医药监事）、夏渊（时任人福医药职工监事）、吴亚 君（时任人福医药财务总监）、张红杰（时任人福医药副总裁）、李前伦（时任人福医药董事会秘书） 收到中国证券监督管理委员会湖北监管局的行政处罚决定书。经查明，人福医药未及时披露2021年至 2022年3月期间非经营性资金占用累计127.85亿元，2020年年度报告存在重大遗漏且虚假记载，虚增归 母净利润1.43亿元；2021年年度报告及2022年半年度报告存在虚假记载，分别虚增归母净利润0.72亿 元、0.91亿元；未及时披露与关联方珂美立德16.45亿元的物业资产交易，2022年年度报告存在重大遗 漏；控股股东当代集团隐瞒关联关系导致信息披露违规。对人福医药上述行为，责令给予警告，并合计 处以850.00万元罚款；对当代集团合计处以900.00万元罚款；对艾路明处以390.00万元罚款，并采取七 年证券市场禁入措施；对李杰给予警告，并处 ...

ST人福公告，公司及相关责任人于2025年12月29日收到中国证监会湖北监管局出具的《行政处罚决定 书》。经查明，人福医药、当代集团存在以下违法事实：一、人福医药未及时披露非经营性资金占用， 2020年年度报告存在重大遗漏；二、人福医药未及时披露关联交易，2022年年度报告存在重大遗漏； 三、人福医药2020年年度报告、2021年年度报告、2022年半年度报告存在虚假记载；四、控股股东当代 集团隐瞒关联关系。湖北证监局决定，对武汉当代科技产业集团股份有限公司处以900万元罚款，对人 福医药集团股份公司给予警告并处以850万元罚款，对时任当代集团董事艾路明处以390万元罚款并采取 七年市场禁入措施。 ...

上交所对人福医药集团股份公司有关责任人予以公开谴责。 ...

公司及相关责任人于 2025 年 12 月 29 日收到中国证监会湖北监管局出具的《行 政处罚决定书》（〔2025〕10 号），现将相关情况公告如下： 一、《行政处罚决定书》主要内容 当事人：人福医药集团股份公司（以下简称人福医药），住所：湖北省武汉市东 湖高新区。 武汉当代科技产业集团股份有限公司（以下简称当代集团），住所：湖北省武汉 市东湖新技术开发区。 证券代码：600079 证券简称：ST 人福 编号：临 2025-133 人福医药集团股份公司 关于收到中国证券监督管理委员会湖北监管局 《行政处罚决定书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 人福医药集团股份公司（以下简称"公司"）及原控股股东武汉当代科技产业集 团股份有限公司（以下简称"当代科技"）于 2024 年 10 月 22 日收到中国证券监督 管理委员会（以下简称"中国证监会"）《立案告知书》（编号：证监立案字 0052024007 号），因涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国 行政处罚法》等法律法规，中国证监会 ...

格隆汇12月29日｜ST人福公告，公司及原控股股东武汉当代科技产业集团股份有限公司因涉嫌信息披 露违法违规，收到中国证监会《行政处罚决定书》。根据《证券法》规定，对人福医药集团股份公司未 及时披露2021年至2022年3月非经营性资金占用的行为，给予警告，并处以350万元的罚款；对人福医药 集团股份公司2020年年度报告重大遗漏和虚假记载，2021年年度报告虚假记载，2022年半年度报告虚假 记载，2022年年度报告重大遗漏的行为，给予警告，并处以500万元的罚款。对武汉当代科技产业集团 股份有限公司指使人福医药2021年至2022年3月为其提供资金，导致人福医药未及时履行信息披露的行 为，处以400万元的罚款。 ...

Report Industry Investment Rating - Not provided in the given content Core Viewpoints - The short - term stock index may fluctuate, but the trend remains unchanged, and it is expected to attack the previous high. The shock digestion since November has entered the end, and from December to January of the next year, it is likely to enter the window period of cross - year layout. The market is expected to show a shock climb again. The mid - term view of being bullish on the stock index remains unchanged. It is recommended to layout and go long on the spring market of the stock index. In terms of operation, hold mid - term long positions and continue to add positions opportunistically; hold call options. [13] Summary by Directory 1. Weekly Views and Strategies Fundamental Views - Last week, the broader market continued to rebound and continuously stood above the 60 - day moving average. The four major indexes all rose, with the small - and medium - cap indexes leading the gains. Most of the style indexes rose, with the growth and cyclical style indexes leading the gains, and only the consumer style index falling. Most of the Shenwan industries rose, with the non - ferrous metals, military, electrical equipment, and electronics sectors leading the gains, while the tourism, banking, coal, and food and beverage sectors led the losses. [8][18][21] - In November 2025, the manufacturing PMI was 49.2%, up 0.2 percentage points from the previous month; the non - manufacturing PMI was 49.5%, down 0.7 percentage points from the previous month. The supply and demand sides of the manufacturing PMI rebounded slightly in November, with the new export orders rebounding by a relatively large 1.7%, which is related to the mitigation of Sino - US tariffs; the ex - factory price and the purchase price of raw materials rebounded again after two months of decline. [8][36] - The growth rate of medium - and long - term credit has been falling continuously for 30 months to 5.89% as of November 2025, and continues to decline. [8][47] - The Politburo set the tone for the real estate market to stop falling and stabilize, and boost the capital market; the State Council issued the new Nine - Article Guidelines to strongly support investor returns; the central bank created two new types of monetary policy tools; the implementation plan for promoting the entry of medium - and long - term funds into the market was officially released, which is expected to add 800 billion yuan of long - term funds to the A - share market annually. [8][55] - The A - share performance showed signs of stabilization in the first quarter, declined in the second quarter, and continued to stabilize and rebound in the third quarter. The performance of the four major indexes rebounded again in the third quarter of 2025. [8][73][77] - The Shanghai Composite Index's valuation is 16.5341, with an upper - limit value of 15.66, and it is at the 87.09th percentile since 2010, at a relatively high level since 2010. However, as performance rises, the valuation will decline. The ChiNext valuation is at a relatively low level. [10][90][92] - In terms of margin trading, the net inflow in 2024 was 274.8 billion yuan; as of December 25, 2025, the net inflow in 2025 was 674.3 billion yuan, and the net inflow in the first five trading days was 45.9 billion yuan. The scale of private securities investment funds increased by 1.7946 trillion yuan this year, and the total scale is currently 7.0076 trillion yuan. The newly registered scale this year is 386 billion yuan. The market value of A - shares held by insurance funds increased by 552.4 billion yuan in the third quarter of 2025, with a month - on - month increase of 18.00%. As of September 30, 2025, the newly established share of stock - type funds was 323.3 billion, and that of hybrid funds was 103.6 billion. The net inflow of index funds in 2025 was 104.9 billion yuan, while the net outflow of active equity funds was 444.9 billion yuan. From April 7 to December 19, 2025, the ETF scale increased by 176.3 billion yuan, and last week it increased by 47.3 billion yuan. As of December 19, the net inflow of ETF funds this year was 79.3 billion yuan. [11][97][101] Strategy Views and Outlook - The broader market fluctuated and rose for eight consecutive days last Friday, with a dive during the session and the trading volume increased to more than 2 trillion yuan, remaining above the 60 - day moving average. The market sentiment declined, and there may be short - term fluctuations, but the trend remains unchanged, and it is expected to attack the previous high. It is recommended to layout and go long on the spring market of the stock index. In terms of operation, hold mid - term long positions and continue to add positions opportunistically; hold call options. [13] 2. Index Industry Trend Review - Last week, the broader market continued to rebound and continuously stood above the 60 - day moving average. The four major indexes all rose, with the small - and medium - cap indexes leading the gains. Most of the style indexes rose, with the growth and cyclical style indexes leading the gains, and only the consumer style index falling. Most of the Shenwan industries rose, with the non - ferrous metals, military, electrical equipment, and electronics sectors leading the gains, while the tourism, banking, coal, and food and beverage sectors led the losses. [8][18][21] 3. Main Contract and Basis Trend - The four major indexes continued to rebound. In terms of the basis, it started from the quarterly main contract and is at a relatively high level. In terms of the arbitrage of each main contract, IC/IF and IC/IH fluctuated and stabilized, IH/IF stabilized; IM/IF and IM/IH fluctuated weakly; IM/IC fluctuated and declined. [25][30] 4. Policy and Economy Economy - In November 2025, the manufacturing PMI was 49.2%, up 0.2 percentage points from the previous month; the non - manufacturing PMI was 49.5%, down 0.7 percentage points from the previous month. The supply and demand sides of the manufacturing PMI rebounded slightly in November, with the new export orders rebounding by a relatively large 1.7%, which is related to the mitigation of Sino - US tariffs; the ex - factory price and the purchase price of raw materials rebounded again after two months of decline. [36] - Generally, PPI leads the inventory cycle. PPI bottomed out and rebounded in June 2023, weakened after two months, and the decline has been narrowing continuously since March 2024. The decline of PPI has been narrowing again since November 2025. In October, the operating revenue of industrial enterprises fell to 1.8%, the inventory continued to rise to 3.7%, demand declined, and there was passive inventory replenishment. [39] - China's social financing scale in November was 2488.5 billion yuan, an increase of 152.8 billion yuan compared with the same period last year. Among them, new RMB loans were 405.3 billion yuan, a decrease of 117 billion yuan compared with the same period last year, mainly due to a decrease of 206.3 billion yuan in household loans. Government bonds were 1204.1 billion yuan, a decrease of 106 billion yuan compared with the same period last year. [42] - The growth rate of medium - and long - term credit has been falling continuously for 30 months to 5.89% as of November 2025, and continues to decline. [47] Policy - New Nine - Article Guidelines: It aims to improve the overall quality of listed companies from the source and promote listed companies to pay more attention to rewarding shareholders. [51] - Implementation Plan for Promoting the Entry of Medium - and Long - Term Funds into the Market: It includes measures such as increasing the actual investment ratio, extending the assessment period, and forming a joint force to implement incremental policies, which is expected to bring a large amount of long - term funds into the A - share market. [54] - The Politburo set the tone for the real estate market to stop falling and stabilize, and boost the capital market, including measures to boost the capital market, promote the entry of medium - and long - term funds, support mergers and acquisitions of listed companies, and promote the stable development of the real estate market. [55] - The central bank created new monetary policy tools, including a swap facility for securities, funds, and insurance companies and a stock repurchase and increase re - loan, and carried out MLF operations and reverse repurchase operations, and adjusted relevant interest rates. [58] - A large - scale debt - resolution measure was announced, which will directly increase 10 trillion yuan of local debt - resolution funds and significantly reduce the local debt - resolution pressure. [59] - Accelerate the construction of first - class investment banks and investment institutions to better promote the high - quality development of the capital market, including implementing differentiated supervision for different types of securities companies. [60] - The 14th Five - Year Plan: It is a crucial five - year period with multiple strategic goals to be achieved. It involves aspects such as the international trade pattern, Sino - US relations, supply - chain reconstruction, and domestic economic development. [63] - The US mid - term elections: The policy environment in the next year will be more favorable for risk assets. The mid - term election schedule and expected fiscal support are also mentioned. [64][66] 5. Revenue and Net Profit of Each Index - The A - share performance showed signs of stabilization in the first quarter, declined in the second quarter, and continued to stabilize and rebound in the third quarter. The performance of the four major indexes rebounded again in the third quarter of 2025. [73][77] 6. Valuation - The Shanghai Composite Index's valuation is 16.5341, with an upper - limit value of 15.66, and it is at the 87.09th percentile since 2010, at a relatively high level since 2010. However, as performance rises, the valuation will decline. The ChiNext valuation is at a relatively low level. [10][90][92] 7. Federal Reserve Interest Rate - Not provided in the given content 8. Capital Flow - In terms of margin trading, the net inflow in 2024 was 274.8 billion yuan; as of December 25, 2025, the net inflow in 2025 was 674.3 billion yuan, and the net inflow in the first five trading days was 45.9 billion yuan. [97] - The scale of private securities investment funds increased by 1.7946 trillion yuan this year, and the total scale is currently 7.0076 trillion yuan. The newly registered scale this year is 386 billion yuan. [101] - The market value of A - shares held by insurance funds increased by 552.4 billion yuan in the third quarter of 2025, with a month - on - month increase of 18.00%, and the market value of A - shares held by insurance funds increased by 1.193 trillion yuan in the first three quarters of 2025, with an increase of 758.4 billion yuan after deducting the scale growth. [103][104] - The market value of the national team increased by 4 billion in the third quarter, with little change, while the CSI 300 index rose by 17.9%. The mid - and long - term A - share market value increased by nearly 90 billion in the third quarter, and the market value of A - shares held by mid - and long - term A - share investment entities increased by 1.8145 trillion in the first three quarters of 2025. [106][108] - From April 7 to December 19, 2025, the ETF scale increased by 204 billion yuan; last week, the ETF scale continued to increase by 27.7 billion yuan. As of December 26, the net inflow of ETF funds this year was 107 billion yuan. [111] - As of September 30, 2025, the newly established share of stock - type funds was 323.3 billion, and that of hybrid funds was 103.6 billion. [117] - In October 2025, the deposits of non - bank financial institutions increased by 1.8574 trillion yuan again, and the total deposits of non - bank financial institutions increased by 6.6688 trillion yuan this year. Overall, funds are flowing from the banking system to non - bank channels such as the capital market and wealth management products. [121] - As of last weekend, the IPO financing in 2023 was 356.5 billion yuan; in 2024, it was 67.3 billion yuan; in 2025, it was 125.3 billion yuan. [129] - Last week, the net reduction of major shareholders in the secondary market was 14.2 billion yuan, at a relatively high level. [134] - The unlocking volume in the first half of 2026 is relatively small. [138] 9. Technical Analysis - The daily - line trend charts of the Shanghai 50 Index, CSI 300 Index, CSI 500 Index, and CSI 1000 Index are provided, showing the price trends of these indexes from December 26, 2024, to December 23, 2025. [142][144][146][148]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 二、本次对外投资进展情况 公司于近日收到通知，睿成创投基金首期款2.5亿元已全部缴付到位，实际募集资金为人民币2.5亿元。 三、对公司的影响及拟采取的应对措施 为更好地借助专业投资机构的经验优势及资源优势，拓宽公司投资渠道，公司参与投资睿成创投基金。 本次投资前后，公司合并报表范围不会发生变化。公司本次投资是在保证主营业务正常发展的前提下作 出的投资决策，资金来源为公司自有资金，公司承担的风险敞口以投资额为限，不会影响生产经营活动 的正常运行，亦不会对公司财务及经营业绩产生重大影响，且不存在损害上市公司及全体股东利益的情 形。 目前睿成创投基金尚需完成中国证券投资基金业协会备案，具体实施情况和进度存在不确定性。本基金 后续运作受到经济环境、监管政策、行业周期、投资标的经营管理等多种因素影响，可能面临投资收益 不确定性风险、操作或技术风险等。公司将密切关注标的基金运作及管理情况，督促基金管理人防范各 方面的投资风 ...

芬太尼概念资金流出榜 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 600079 | ST人福 | -2.06 | 1.92 | -4289.17 | | 002262 | 恩华药业 | -0.79 | 0.68 | -1301.84 | | 300482 | 万孚生物 | 0.61 | 0.51 | -515.34 | | 688767 | 博拓生物 | -0.28 | 0.74 | -269.86 | | 688298 | 东方生物 | 0.21 | 0.49 | -200.30 | | 600285 | 羚锐制药 | 0.00 | 0.50 | -11.65 | | 600511 | 国药股份 | 0.00 | 0.54 | 147.46 | | 600420 | 国药现代 | 0.20 | 0.51 | 176.90 | 截至12月24日收盘，芬太尼概念下跌0.26%，位居概念板块跌幅榜前列，板块内，ST人福、恩华药业、 博拓生物等跌幅居前，股价上涨的有3只，涨幅居前的有万孚生物、东方生 ...

证券代码：600079 证券简称：ST 人福 公告编号：2025-132 人福医药集团股份公司 关于参与设立私募基金暨关联交易的进展公告 二、本次对外投资进展情况 公司于近日收到通知，睿成创投基金首期款 2.5 亿元已全部缴付到位，实际募集资 金为人民币 2.5 亿元。 三、对公司的影响及拟采取的应对措施 为更好地借助专业投资机构的经验优势及资源优势，拓宽公司投资渠道，公司参与 投资睿成创投基金。本次投资前后，公司合并报表范围不会发生变化。公司本次投资是 在保证主营业务正常发展的前提下作出的投资决策，资金来源为公司自有资金，公司承 担的风险敞口以投资额为限，不会影响生产经营活动的正常运行，亦不会对公司财务及 经营业绩产生重大影响，且不存在损害上市公司及全体股东利益的情形。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 投资标的名称 | 武汉睿成新药科技成果转化创业投资基金中心（有限合 | | | | | --- | --- | --- | --- | --- | | | 伙） | | | | | 投资金额 ...